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Background
The Surviving Sepsis Campaign recommends targeting a mean 
arterial pressure of at least 65 mmHg during initial resuscitation of 
patients with septic shock. However, whether this blood pressure 
target is more or less effective than a higher target is unknown.
Methods
Objective
To determine whether targeting a mean arterial pressure of 80 to 
85 mmHg would decrease 28-day mortality, as compared with 
targeting a mean arterial pressure of 65 to 70 mmHg. The sub- 
hypothesis of the study was that the beneficial effects of a higher 
target would be more pronounced among patients with chronic 
hypertension.
Design
The Assessment of Two Levels of Arterial Pressure on Survival in 
Patients with Septic Shock (SEPSISPAM) is a multi-center, rand-
omized, stratified, open-label, prospective trial involving patients 
with septic shock. The patients were stratified according to whether 
they had a history of chronic hypertension. The data analysis was 
conducted on an intention-to-treat basis.
Setting
Intensive care units in 29 centers in France from March 2010 
through December 2011.
Subjects
Patients older than 18 years of age who had septic shock refractory 
to fluid resuscitation, required vasopressors at a minimum infusion 
rate of 0.1 mcg/kg/min and evaluated within 6 hours after the ini-
tiation of vasopressors. Subjects were excluded if they had legal 
protection, had no affiliation with French health care system, were 
pregnant, recently participated in another biochemical study or 
another interventional study with mortality as the primary endpoint, 
or were decided by the investigators not to resuscitate.
Intervention
After their enrollment, subjects were assigned to maintain a mean 
arterial pressure of 80 to 85 mmHg (high-target group) or 65 to 
70 mmHg (low-target group) using protocolized hemodynamic 
management strategies that employed norepinephrine as the first 
line vasopressor. Target mean arterial pressure was maintained for 
maximum of 5 days or until the subjects were weaned off from 
vasopressor support.
Outcomes
The primary outcome was death from any cause by 28 days after 
inclusion. Secondary outcomes were 90-day mortality, days alive 
and free from organ dysfunction by day 28, and the length of stay in 
the intensive care unit (ICU) and hospital.
Results
At 28 days, there was no significant between-group difference in 
mortality, with deaths reported in 142 of 388 patients in the high-
target group (36.6%) and 132 of 388 patients in the low-target 
group (34.0%) (hazard ratio in the high-target group, 1.07; 95% 
confidence interval [CI], 0.84 to 1.38; P = 0.57). There was also 
no significant difference in mortality at 90 days, with 170 deaths 
(43.8%) and 164 deaths (42.3%), respectively (hazard ratio, 1.04; 
95% CI, 0.83 to 1.30; P = 0.74). The occurrence of serious adverse 
events did not differ significantly between the two groups (74 events 
[19.1%] and 69 events [17.8%], respectively; P = 0.64). However, 
the incidence of newly diagnosed atrial fibrillation was higher in 
the high-target group than in the low-target group. Among patients 
with chronic hypertension, those in the high-target group required 
less renal-replacement therapy than did those in the low-target 
group, but such therapy was not associated with a difference in 
mortality.
Conclusion
Targeting a mean arterial pressure of 80 to 85 mmHg, as compared 
with 65 to 70 mmHg, in patients with septic shock undergoing 
resuscitation did not result in significant differences in mortality at 
either 28 or 90 days.
Abstract adapted from the original provided courtesy of PubMed: 
A service of the National Library of Medicine and the National 
Institutes of Health.
Commentary
For the patients suffering from septic shock who remain hypoten-
sive despite of adequate fluid resuscitation, the guidelines of the 
Surviving Sepsis Campaign 2012 recommended initial resuscitation 
with vasopressors to maintain a mean arterial pressure (MAP) of at 
least 65 mmHg. For the patients with atherosclerosis or previous 
hypertension, however, the Surviving Sepsis Campaign guidelines 
cautioned that maintaining a higher MAP might be better1.
These recommendations were based on limited, sometimes con-
flicting results from small studies, the committee members’ per-
sonal practice and traditional pressure thresholds used in prior 
clinical trials of sepsis resuscitation that did not study target blood 
pressure levels. Some of these studies revealed that MAP under 
65 mmHg was associated with highest mortality in patients with 
septic shock2, but targeting a MAP higher than 65 mmHg conferred 
no additional benefit3,4. Looking specifically at renal function, how-
ever, other studies found that targeting a higher MAP was beneficial5–7. 
In reality, the majority of critical care practitioners seem to be target-
ing a MAP higher than 65 mmHg8. Clearly, more studies are war-
ranted to determine the optimal MAP target in patients with septic 
shock.
In this context, the Assessment of Two Levels of Arterial Pressure 
on Survival in Patients with Septic Shock (SEPSISPAM) was con-
ducted at 29 centers in France from March 2010 through December 
2011, to determine whether targeting a MAP of 65 to 70 mmHg was 
more or less effective than targeting a higher MAP.
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The hypothesis of this study was based on a sound physiological 
rationale. Human bodies, like in other mammals, require relatively 
high blood pressure to allow autoregulation of blood flow distribution. 
Autoregulation is the intrinsic ability of our organs to maintain a 
constant blood flow despite changes in perfusion pressure. It oper-
ates by changes in local vasomotor tones, but it has its limits. If the 
perfusion pressure falls below a threshold point where the blood 
vessels are already maximally dilated, autoregulation-induced 
local vasodilation will no longer sustain constant organ blood flow. 
At these lower blood pressure limits, organ blood flow usually 
decreases proportionally to the decline in perfusion pressure and 
below the flow needed to support basal metabolism. Ultimately, 
when the perfusion pressure reaches the critical closing pressure or 
outflow pressure, organ flow ceases completely. Hence, it is impor-
tant for critical care practitioners to know their patients’ threshold 
pressure of autoregulation, if they wish their resuscitation targets to 
result in organ perfusion and sustained tissue viability.
Under normal conditions, arteriolar tone will cause vessels to col-
lapse and stop arterial flow once the intraluminal pressure is less than 
the intrinsic arteriolar wall vasomotor tone. This pressure is referred 
to as the vessel’s critical closing pressure or outflow pressure. Criti-
cal closing pressure can be estimated by describing the relation-
ship between input arterial pressure (P) and organ blood flow (Q) 
over a range of pressures and flows9. Plotting P on x-axis and Q 
on y-axis, the slope Q/P represents Ohmic resistance of the vessels. 
Increase in Ohmic resistance leads to increase in perfusion 
pressure necessary to maintain steady organ flow. A caveat here 
is that the blood flow ceases at a pressure much higher than zero. 
For most vascular circuits, the Q/P relationship decays to an 
extrapolated pressure at zero flow (Pzf) which reflects this critical 
closing pressure. The critical closing pressure is a function of arte-
riolar and pre-capillary sphincter tone and varies amongst vascular 
beds, dependent upon overall sympathetic tone and local metabolic 
demands. As a lumped sum parameter, it is thought to be around 
45 mmHg in normal health adults at rest and remains higher than 
the mean systemic filling pressure, even in vasoplegic states. This 
difference between the local critical closing pressure and mean sys-
temic filling pressure signifies the existence of a vascular waterfall 
in the arterial circuit10. With increasing hypotension and its associ-
ated local vasodilation in metabolically active tissues, some minimal 
pressure gradient is ultimately reached, below which flow will 
decrease if arterial input pressure decreases further.
Although the actual organ perfusion pressure is unknown in most 
cases, the discussion is not academic, but highly clinical, because 
it is the organ perfusion pressure that defines whether a given MAP 
is above or below the threshold value that allows autoregulation to 
occur.
Importantly, autoregulation is organ specific11 and can be altered by 
disease processes, including hypertension and sepsis12. Hence, the 
sub-hypothesis of the SEPSISPAM study was that the beneficial 
effects of a higher target MAP would be more pronounced among 
patients with chronic hypertension.
The SEPSISPAM study was well designed. It was a multi-center, 
randomized, stratified, open-label, prospective trial involving patients 
with septic shock. The investigators screened 4,098 patients for 
eligibility, but 3,298 of them were considered not eligible, primarily 
because they did not meet the inclusion criteria. Of 1,682 patients 
who did not meet the inclusion criteria, 858 had shock lasting more 
than 6 hours. Whether or not exclusion of this many patients may 
have impacted the pragmatic nature of study is unknown.
Impressively, the investigators were able to recruit and randomize 
798 patients out of 800 eligible patients. Eventually, 776 patients 
were included in 90-day follow-up and analysis. Baseline charac-
teristics of the two groups were very similar. 167 patients (43%) 
in the high-target group and 173 patients (44.6%) in the low-target 
group had a history of chronic hypertension.
Due to the nature of its intervention, it was necessarily open-label. 
Still, this might have had significant impact on the results. Majority 
of the patients assigned to the high-target group achieved a MAP 
of 85 to 90 mmHg, while majority of the patients assigned to the 
low-target group achieved a MAP of 70 to 75 mmHg. Even though 
the study was able to maintain the difference in MAP between the 
two groups, the inflation in the low-target group’s MAP values 
precluded answers to the question regarding the lowest threshold 
MAP required to preserve the organ blood flow.
This study allowed targeting a MAP using protocolized hemody-
namic management strategies using fluid resuscitation and vaso-
pressors alone. Reportedly, intravenous fluids were administered 
at clinicians’ discretion based on hemodynamic variables such as 
right heart catheterization, pulse pressure and stroke volume meas-
urement or echocardiography, which were also part of the study’s 
inclusion criteria, but those data were not reported. Overall fluid 
resuscitation in both study groups was lower than in previously 
reported studies, suggesting that fluid resuscitation was less vigor-
ous than traditionally performed.
The study showed that there was no significant between-group 
difference in the rate of death at 28 days and at 90 days. For the 
patients with chronic hypertension, the low-target group had a 
higher incidence of the doubling of creatinine level and the need 
for renal replacement therapy. This finding confirms that the opti-
mal MAP differs not only between individual patients, but also 
between individual organs, with those patients with chronic hyper-
tension requiring a higher MAP to prevent renal injury. There is no 
“one-size fits all” when it comes to optimal MAP for a patient with 
septic shock. Critical care practitioners must be able to adjust the 
target MAP based on their patients’ clinical responses, such as urine 
output or serum lactate level. This approach may be difficult when 
it comes to the assessment of cerebral blood flow, as there are no 
reliable clinical indicators. Outcomes on neurocognitive functions 
were not reported in this study, but they are anticipated to be part of 
the upcoming sub-study report13.
Importantly, targeting a higher MAP in all patients, including those 
without hypertension, was also not without risk. Although this study 
was underpowered to detect any differences in incidence of most of 
the adverse events, which were rare, the majority of adverse events 
were reported higher in the high-target group. These findings are not 
surprising because the infusion rates and the duration of vasopressors 
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were higher in the high-target group. The incidence of newly diag-
nosed atrial fibrillation was significantly higher in the high-target 
group, with events reported in 26 patients (6.7%) in the high-target 
group and 11 patients (2.8%) in the low-target group. New onset atrial 
fibrillation may be associated with increased incidence of in-hospital 
stroke and death14. The investigators limited the types of vasopressor 
used with norepinephrine as the primary choice. If vasopressin had 
been used, which is known to be associated with less tachyarrhythmia, 
the adverse event profile might have looked different15.
Finally, the generalizability of the study may have been limited 
because of the frequent use of corticosteroids and occasional 
use of activated protein C, which do not represent present-day 
standard of care. Corticosteroids were used in 327 patients (85%) 
in the high-target group and 307 patients (80%) in the low-target 
group. Activated protein C was used in 29 patients (7.5%) in the 
high-target group and 26 patients (6.8%) in the low-target group.
Still, these data reflect the largest and best-controlled study of 
targeted blood pressure in septic shock published to date. They 
support the conclusion that targeting a MAP of 65 to 70 mmHg in 
a patient without prior chronic hypertension is a reasonable first 
approximation, after which time MAP levels can be adjusted up 
or down as end organ function dictates. Whereas in the patient 
with chronic hypertension, a higher baseline MAP around 80 to 
85 mmHg is appropriate with similar post target changes made as 
end-organ perfusion defines.
Recommendation
The findings of this study underscore the importance of personal-
ized medicine during resuscitation from septic shock. While target-
ing a MAP of 65 to 70 mmHg is a reasonable first step, critical care 
practitioners must be able to adjust the target MAP based on their 
patients’ subsequent clinical response. Targeting a higher MAP 
around 80 to 85 mmHg appears to be a reasonable first step for a 
patient with chronic hypertension, but it should be done with cau-
tion because higher doses and duration of vasopressors will be nec-
essary and will carry increase risk of cardiovascular complications.
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